Literature DB >> 19916900

Age distribution of paediatric rotavirus gastroenteritis cases in Europe: the REVEAL study.

Carlo Giaquinto1, Pierre van Damme.   

Abstract

Rotavirus is the most frequent cause of severe diarrhoea in children aged <5 y. A prospective, multicentre, observational study was conducted in Europe during the 2004-2005 rotavirus season. The study was undertaken in areas of Belgium, France, Germany, Italy, Spain, Sweden, and the UK, to estimate the incidence of community-acquired acute gastroenteritis (AGE) and rotavirus gastroenteritis (RVGE) in children under 5 y of age seeking medical care in 3 settings: primary care, emergency department, and hospital. A post-hoc analysis was done to further describe the age distribution of children with RVGE. The study included 2846 children with AGE. Of 2712 children for whom ELISA results were available, 1102 (40.6%) were rotavirus-positive to the results section well. Overall, 86.1% of RVGE cases occurred in children aged between 3 months and 3 y, whereas 1.8% of cases were observed in infants aged less than 3 months. A total of 3.6% of cases occurred in children aged more than 4 y. These results suggest that, in Europe, routine vaccination for rotavirus should be offered to all infants in early childhood to be effective during the main at-risk period. This could significantly reduce the substantial burden of this potentially serious childhood disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19916900     DOI: 10.3109/00365540903380495

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  29 in total

1.  Results from a randomized clinical trial of coadministration of RotaTeq, a pentavalent rotavirus vaccine, and NeisVac-C, a meningococcal serogroup C conjugate vaccine.

Authors:  Timo Vesikari; Aino Karvonen; Ray Borrow; Nick Kitchin; Martine Baudin; Stéphane Thomas; Anne Fiquet
Journal:  Clin Vaccine Immunol       Date:  2011-03-09

2.  Burden and genotyping of rotavirus disease in the United Arab Emirates: a multicenter hospital-based surveillance.

Authors:  Mohammad Howidi; Ghazala Balhaj; Hakam Yaseen; Kusuma Gopala; Leen Jan Van Doorn; Rodrigo DeAntonio
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 3.  Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2010-06-18       Impact factor: 9.546

4.  Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children below five years of age in Romania.

Authors:  Ioana Alina Anca; Florentina Ligia Furtunescu; Doina Pleşca; Adrian Streinu-Cercel; Sorin Rugină; Katsiaryna Holl
Journal:  Germs       Date:  2014-06-02

5.  Coinfection in acute gastroenteritis predicts a more severe clinical course in children.

Authors:  D Valentini; A C Vittucci; A Grandin; A E Tozzi; C Russo; M Onori; D Menichella; A Bartuli; A Villani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-31       Impact factor: 3.267

6.  Lack of evidence of rotavirus-dependent molecular mimicry as a trigger of coeliac disease.

Authors:  F Ziberna; G De Lorenzo; V Schiavon; F Arnoldi; S Quaglia; L De Leo; S Vatta; S Martelossi; O R Burrone; A Ventura; T Not
Journal:  Clin Exp Immunol       Date:  2016-09-29       Impact factor: 4.330

7.  Impact of vaccination uptake on hospitalizations due to rotavirus acute gastroenteritis in 2 different socioeconomic areas of Spain.

Authors:  Francisco Giménez Sánchez; Esperanza Jiménez Nogueira; Miguel Sánchez Forte; Mercedes Ibáñez Alcalde; Elvira Cobo; Raquel Angulo; Pablo Garrido Fernández
Journal:  Hum Vaccin Immunother       Date:  2016-04-02       Impact factor: 3.452

8.  Infections and risk of celiac disease in childhood: a prospective nationwide cohort study.

Authors:  Karl Mårild; Christian R Kahrs; German Tapia; Lars C Stene; Ketil Størdal
Journal:  Am J Gastroenterol       Date:  2015-09-08       Impact factor: 10.864

9.  Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study.

Authors:  Tessa Braeckman; Koen Van Herck; Nadia Meyer; Jean-Yves Pirçon; Montse Soriano-Gabarró; Elisabeth Heylen; Mark Zeller; Myriam Azou; Heidi Capiau; Jan De Koster; Anne-Sophie Maernoudt; Marc Raes; Lutgard Verdonck; Marc Verghote; Anne Vergison; Jelle Matthijnssens; Marc Van Ranst; Pierre Van Damme
Journal:  BMJ       Date:  2012-08-08

10.  Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial.

Authors:  Sheila Isanaka; Céline Langendorf; Monica Malone McNeal; Nicole Meyer; Brian Plikaytis; Souna Garba; Nathan Sayinzoga-Makombe; Issaka Soumana; Ousmane Guindo; Rockyiath Makarimi; Marie Francoise Scherrer; Eric Adehossi; Iza Ciglenecki; Rebecca F Grais
Journal:  PLoS Med       Date:  2021-07-02       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.